<DOC>
	<DOC>NCT01608542</DOC>
	<brief_summary>This is a single and multiple dose study in healthy male and female (of non-child bearing potential) Japanese volunteers, to assess the blood and urine drug levels of Fostamatinib. Fostamatinib is being developed for the treatment of rheumatoid arthritis.</brief_summary>
	<brief_title>A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects</brief_title>
	<detailed_description>A Phase I, Open-label Study to Assess the Pharmacokinetics of Oral Fostamatinib in Healthy Japanese Subjects After Single and Multiple Doses</detailed_description>
	<criteria>Healthy male and female (of nonchildbearing potential) Japanese subjects 20 to 45 years of age Body mass index (BMI) between 17 and 27 kg/m2 and weigh at least 45 kg and no more than 100 kg History or presence of respiratory, GI, renal, hepatic, hematological, lymphatic, neurological, cardiovascular, psychiatric, musculoskeletal, genitourinary, immunological, dermatological, connective tissue diseases or disorders Any clinically significant illness, acute infection, known inflammatory process, medical/surgical procedure or trauma within 4 weeks of the first administration of investigational product Smoking in excess of 5 cigarettes per day or equivalent within 30 days of Day 1 Use of prescription or overthecounter drugs within 2 weeks of first administration of investigational product Previous participation in a fostamatinib study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>fostamatinib</keyword>
	<keyword>FosD</keyword>
	<keyword>Japanese Healthy volunteers</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Single and Multiple Dose Study</keyword>
</DOC>